SCHEMBL8536231

SCHEMBL8536231

CCCCc1ncc(C(C)(Cc2ccccc2)C(=O)O)n1Cc1ccccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7055318 0.89 — —
SCHEMBL7549368 0.83 — —
SCHEMBL7059057 0.82 — —
SCHEMBL7622834 0.81 — —
SCHEMBL9210894 0.81 — —
SCHEMBL9210887 0.81 — —
SCHEMBL7549372 0.80 — —
SCHEMBL7622829 0.80 — —
SCHEMBL9207265 0.80 — —
SCHEMBL9205297 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5824696-A ANGIOTENSIN II RECEPTOR ANTAGONIST AS ANTIINFLAMMATORY AGENTS USING HETEROCYCLIC ACID COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-10-20 — — US disclosed
WO-1992002510-A1 SUBSTITUTED [1H-IMIDAZOL-5-YL]ALKANOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1992-02-20 — — WO disclosed
Send feedback